European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

J Eur Acad Dermatol Venereol

Division of Evidence-Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Published: December 2017

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.14454DOI Listing

Publication Analysis

Top Keywords

european s3-guideline
4
s3-guideline systemic
4
systemic treatment
4
treatment psoriasis
4
psoriasis vulgaris
4
vulgaris update
4
update apremilast
4
apremilast secukinumab
4
secukinumab edf
4
edf cooperation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!